Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
North Carolina – Regional Life Sciences Roundup -October 23th, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection […]
Read More →North Carolina – Regional Life Sciences Roundup – November 13, 2026 North Carolina’s health systems are making moves this week. Leadership transitions are happening at the top while new facilities and partnerships are taking shape on the ground. Atrium Health committed to a three-year partnership supporting a $62 million pediatric behavioral health facility opening in […]
How three core values showed up at the Lilly Lehigh Valley groundbreaking, and what this project already means to the region For now, it’s a grass and dirt field off Main Street in Fogelsville, Pennsylvania. On Thursday afternoon, under a white tent and a gray November sky, Lilly leaders, Pennsylvania officials, and local partners gathered […]
WINSTON-SALEM, N.C. – Novant Health today announced that Carl S. Armato, president and CEO, will retire effective Dec.
App combines continuing education, credential management, career development, and community all in one place
Recognition celebrates the people behind its Direct-to-Patient Site model, the innovative, radically transparent culture, and the company's commitment to clinical quality
Almac Clinical Services has won the Supply Chain Excellence Award at the CPHI Pharma Awards 2026, recognising the successful application of Almac Adapt™ in a complex, time-critical advanced therapy clinical study.
DURHAM, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) — Priovant Therapeutics today announced the publication in JAMA Dermatology of results from the Phase 2 portion of the BEACON study, a randomized, double-blind,…
– First patient completed observation period following PBGENE-DMD treatment with no reported safety concerns –
November 10, 2026 09:00 ET | Source: Metabolon, Inc. Metabolon, Inc.
